Ratios Revealed: Decoding Heron Therapeutics Inc (HRTX)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Heron Therapeutics Inc (NASDAQ: HRTX) was $1.18 for the day, down -3.28% from the previous closing price of $1.22. In other words, the price has decreased by -$3.28 from its previous closing price. On the day, 5.36 million shares were traded. HRTX stock price reached its highest trading level at $1.25 during the session, while it also had its lowest trading level at $1.13.

Ratios:

Our analysis of HRTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.

On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.

Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 179472096 and an Enterprise Value of 286828000. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30. Its current Enterprise Value per Revenue stands at 2.082 whereas that against EBITDA is -50.365.

Stock Price History:

Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -28.79%, while the 200-Day Moving Average is calculated to be -52.45%.

Shares Statistics:

HRTX traded an average of 1.83M shares per day over the past three months and 1446360 shares per day over the past ten days. A total of 151.70M shares are outstanding, with a floating share count of 151.01M. Shares short for HRTX as of 1731628800 were 27910496 with a Short Ratio of 15.27, compared to 1728950400 on 30643570. Therefore, it implies a Short% of Shares Outstanding of 27910496 and a Short% of Float of 23.709999.

Most Popular